chr13-39655727-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020751.3(COG6):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000879 in 1,592,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 34)
Exomes š: 0.0000090 ( 0 hom. )
Consequence
COG6
NM_020751.3 start_lost
NM_020751.3 start_lost
Scores
5
2
9
Clinical Significance
Conservation
PhyloP100: 2.95
Genes affected
COG6 (HGNC:18621): (component of oligomeric golgi complex 6) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-39655727-A-G is Pathogenic according to our data. Variant chr13-39655727-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 487579.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG6 | NM_020751.3 | c.1A>G | p.Met1? | start_lost | 1/19 | ENST00000455146.8 | NP_065802.1 | |
COG6 | NM_001145079.2 | c.1A>G | p.Met1? | start_lost | 1/19 | NP_001138551.1 | ||
COG6 | XM_011535168.2 | c.1A>G | p.Met1? | start_lost | 1/20 | XP_011533470.1 | ||
COG6 | NR_026745.1 | n.101A>G | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG6 | ENST00000455146.8 | c.1A>G | p.Met1? | start_lost | 1/19 | 1 | NM_020751.3 | ENSP00000397441 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
1
AN:
152242
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000469 AC: 1AN: 213312Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 116302
GnomAD3 exomes
AF:
AC:
1
AN:
213312
Hom.:
AF XY:
AC XY:
0
AN XY:
116302
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000902 AC: 13AN: 1440620Hom.: 0 Cov.: 40 AF XY: 0.0000112 AC XY: 8AN XY: 714792
GnomAD4 exome
AF:
AC:
13
AN:
1440620
Hom.:
Cov.:
40
AF XY:
AC XY:
8
AN XY:
714792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74374
GnomAD4 genome
AF:
AC:
1
AN:
152242
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
COG6-congenital disorder of glycosylation Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center | Dec 20, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Pathogenic
D;D;.
Sift4G
Pathogenic
D;D;D
Polyphen
0.014
.;B;.
Vest4
MutPred
Gain of catalytic residue at E3 (P = 0.0926);Gain of catalytic residue at E3 (P = 0.0926);Gain of catalytic residue at E3 (P = 0.0926);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at